253 related articles for article (PubMed ID: 10732773)
1. Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs.
Screnci D; McKeage MJ; Galettis P; Hambley TW; Palmer BD; Baguley BC
Br J Cancer; 2000 Feb; 82(4):966-72. PubMed ID: 10732773
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin.
Screnci D; Er HM; Hambley TW; Galettis P; Brouwer W; McKeage MJ
Br J Cancer; 1997; 76(4):502-10. PubMed ID: 9275028
[TBL] [Abstract][Full Text] [Related]
3. Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model.
Luo FR; Wyrick SD; Chaney SG
Cancer Chemother Pharmacol; 1999; 44(1):29-38. PubMed ID: 10367746
[TBL] [Abstract][Full Text] [Related]
4. Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model.
Holmes J; Stanko J; Varchenko M; Ding H; Madden VJ; Bagnell CR; Wyrick SD; Chaney SG
Toxicol Sci; 1998 Dec; 46(2):342-51. PubMed ID: 10048138
[TBL] [Abstract][Full Text] [Related]
5. Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the rat.
McKeage MJ; Boxall FE; Jones M; Harrap KR
Cancer Res; 1994 Feb; 54(3):629-31. PubMed ID: 8306321
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.
McDonald ES; Randon KR; Knight A; Windebank AJ
Neurobiol Dis; 2005 Mar; 18(2):305-13. PubMed ID: 15686959
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity.
Shord SS; Bernard SA; Lindley C; Blodgett A; Mehta V; Churchel MA; Poole M; Pescatore SL; Luo FR; Chaney SG
Anticancer Res; 2002; 22(4):2301-9. PubMed ID: 12174918
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss.
Jamieson SM; Liu J; Connor B; McKeage MJ
Cancer Chemother Pharmacol; 2005 Oct; 56(4):391-9. PubMed ID: 15887017
[TBL] [Abstract][Full Text] [Related]
10. Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity.
Liu JJ; Jamieson SM; Subramaniam J; Ip V; Jong NN; Mercer JF; McKeage MJ
Cancer Chemother Pharmacol; 2009 Sep; 64(4):847-56. PubMed ID: 19466412
[TBL] [Abstract][Full Text] [Related]
11. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.
Cavaletti G; Petruccioli MG; Marmiroli P; Rigolio R; Galbiati S; Zoia C; Ferrarese C; Tagliabue E; Dolci C; Bayssas M; Griffon Etienne G; Tredici G
Anticancer Res; 2002; 22(6C):4199-204. PubMed ID: 12553056
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats.
Luo FR; Wyrick SD; Chaney SG
Cancer Chemother Pharmacol; 1999; 44(1):19-28. PubMed ID: 10367745
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs.
McKeage MJ; Hsu T; Screnci D; Haddad G; Baguley BC
Br J Cancer; 2001 Oct; 85(8):1219-25. PubMed ID: 11710838
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective interactions in rats between paclitaxel and cisplatin.
McKeage MJ; Haddad GG; Ding L; Galettis P; Screnci D; Zhuang L; Baguley BC
Oncol Res; 1999; 11(6):287-93. PubMed ID: 10691031
[TBL] [Abstract][Full Text] [Related]
15. The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum.
Cerri S; Piccolini VM; Santin G; Bottone MG; De Pascali SA; Migoni D; Iadarola P; Fanizzi FP; Bernocchi G
Neurotoxicol Teratol; 2011; 33(2):273-81. PubMed ID: 20883777
[TBL] [Abstract][Full Text] [Related]
16. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
[TBL] [Abstract][Full Text] [Related]
17. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding.
Ta LE; Espeset L; Podratz J; Windebank AJ
Neurotoxicology; 2006 Dec; 27(6):992-1002. PubMed ID: 16797073
[TBL] [Abstract][Full Text] [Related]
19. Different accumulation of cisplatin, oxaliplatin and JM216 in sensitive and cisplatin-resistant human cervical tumour cells.
Martelli L; Di Mario F; Ragazzi E; Apostoli P; Leone R; Perego P; Fumagalli G
Biochem Pharmacol; 2006 Sep; 72(6):693-700. PubMed ID: 16844093
[TBL] [Abstract][Full Text] [Related]
20. Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo.
Fischer SJ; McDonald ES; Gross L; Windebank AJ
Neurobiol Dis; 2001 Dec; 8(6):1027-35. PubMed ID: 11741398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
